MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
DarioHealth Corp. ROCE Ratio 2011-2026 | DRIO
Annual ROCE Ratio DarioHealth Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -66.97 | -56.9 | -88.54 | -105.39 | -91.5 | -198.18 | -365.78 | -1143.82 | -227.28 | -741.91 | -519.7 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -56.9 | -1143.82 | -327.82 |
Quarterly ROCE Ratio DarioHealth Corp.
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -41.04 | -45.5 | -51.63 | -43.65 | -59.45 | -62.04 | -59.43 | -42.38 | -55.07 | -51.97 | -53.07 | -40.54 | -62.09 | -70.94 | -72.22 | -49.55 | -73.0 | -74.91 | -74.31 | -74.03 | -88.84 | -80.2 | -93.94 | -71.58 | -117.0 | -147.61 | -184.14 | -142.99 | -218.58 | -248.75 | -288.33 | -286.78 | -245.18 | -127.99 | 16.6 | 111.1 | 272.3 | 391.91 | 447.5 | 369.37 | 416.71 | 302.86 | 275.21 | 165.78 | 3930.9 | 7648.67 | 11762.02 | 11523.26 | 11618.97 | 7949.57 | 3849.21 | 223.03 | 223.03 | 127.32 | 46.28 | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 11762.02 | -288.33 | 1057.69 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-486.78 | - | -6.19 % | $ 10.5 M |  USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Brainsway Ltd.
BWAY
|
-17.75 | $ 23.08 | 1.7 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 29.14 | -3.75 % | $ 326 M |  China |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
-293.94 | $ 1.1 | 0.46 % | $ 1.4 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
Co-Diagnostics
CODX
|
-47.68 | - | - | $ 79.8 M | USA |
 |
DexCom
DXCM
|
33.2 | $ 70.29 | 8.0 % | $ 27.4 B | USA |
 |
Celcuity
CELC
|
-97.97 | $ 103.65 | -1.16 % | $ 4.09 B | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 32.89 | 3.09 % | $ 914 M | USA |
 |
Danaher Corporation
DHR
|
9.82 | $ 211.14 | -1.74 % | $ 154 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.86 | $ 205.13 | -0.82 % | $ 22.8 B | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 23.24 | 1.18 % | $ 703 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
CareDx, Inc
CDNA
|
-77.82 | $ 19.6 | 2.62 % | $ 1.05 B | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Interpace Biosciences
IDXG
|
-365.72 | $ 1.85 | - | $ 8.12 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-36.48 | $ 103.32 | 0.09 % | $ 19.1 B | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
Lantheus Holdings
LNTH
|
42.0 | $ 68.71 | -0.02 % | $ 4.75 B | USA |
 |
Guardant Health
GH
|
317.65 | $ 104.76 | 1.95 % | $ 12.9 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.9 | - | - | $ 10.6 B |  Niderland |
 |
National Research Corporation
NRC
|
81.8 | $ 12.09 | -5.81 % | $ 297 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
6.57 | $ 160.2 | 0.91 % | $ 8.23 B | USA |
 |
IDEXX Laboratories
IDXX
|
50.7 | $ 627.58 | 1.68 % | $ 51.8 B | USA |
 |
Illumina
ILMN
|
-35.1 | $ 115.9 | 1.27 % | $ 18.4 B | USA |
 |
OPKO Health
OPK
|
-7.58 | $ 1.24 | 2.48 % | $ 861 M | USA |
 |
IQVIA Holdings
IQV
|
36.29 | $ 166.72 | -1.27 % | $ 30.2 B | USA |
 |
Natera
NTRA
|
-76.66 | $ 204.66 | -1.53 % | $ 20.1 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 31.11 | -0.94 % | $ 20 B | Niderland |
|
Biodesix
BDSX
|
-41.6 | $ 11.55 | 6.6 % | $ 1.5 B | USA |
 |
Personalis
PSNL
|
-33.64 | $ 8.22 | -2.09 % | $ 487 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
13.5 | $ 281.39 | 1.13 % | $ 23.6 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 95.34 | 19.06 % | $ 7.86 B |  Irlanda |
 |
Quidel Corporation
QDEL
|
69.35 | $ 23.61 | -0.55 % | $ 995 M | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.25 | 4.19 % | $ 5.17 M | USA |
 |
Bioventus
BVS
|
-47.08 | $ 8.22 | 1.48 % | $ 515 M | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 429.09 | 3.14 % | $ 12.4 B | USA |